|
|
|
|
| LEADER |
01025nam a2200217 a 4500 |
| 001 |
1831727 |
| 005 |
20171111234616.0 |
| 008 |
121114s2011 dcua sb 000 0 eng d |
| 020 |
|
|
|z 9780309219297 (e-book)
|
| 040 |
|
|
|a CaPaEBR
|
| 050 |
1 |
4 |
|a R853.C55
|b P83 2011eb
|
| 245 |
0 |
0 |
|a Public engagement and clinical trials
|b new models and disruptive technologies : workshop summary /
|c Victoria Weisfeld, Rebecca A. English, and Anne B. Clairborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation Board on Health Sciences Policy, Institute of Medicine of the National Academies.
|
| 260 |
|
|
|a Washington, D.C. :
|b National Academies Press,
|c 2011.
|
| 300 |
|
|
|a xvi, 99 p. :
|b col. ill.
|
| 504 |
|
|
|a Includes bibliographical references.
|
| 650 |
|
0 |
|a Clinical trials.
|
| 700 |
1 |
|
|a English, Rebecca A.
|
| 700 |
1 |
|
|a Claiborne, Anne B.
|
| 710 |
2 |
|
|a Institute of Medicine (U.S.)
|
| 856 |
4 |
0 |
|a ebrary, Inc.
|u http://site.ebrary.com/lib/ucy/Doc?id=10506513
|
| 952 |
|
|
|a CY-NiOUC
|b 5a045dd16c5ad14ac1edb4cf
|c 998a
|d 945l
|e -
|t 1
|x m
|z Books
|
